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Stress-Induced c-Fos Expression is Differentially Modulated
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Immobilization stress upregulates c-Fos expression in several CNS areas. Repeated stress or the use of drugs can modulate stress-
induced c-Fos expression. Here, we investigated in 40 different areas of the rat brain the effects of dexamethasone (SDX, a synthetic
glucocorticoid), diazepam (SBDZ, a benzodiazepine), and imipramine (IMI, an antidepressant) on the c-Fos expression induced by
restraint stress. Wistar rats were divided into four groups and submitted to 20 days of daily injection of saline (three first groups) or
imipramine, 15 mg/kg, i.p. On day 21, animals were submitted to injections of saline (somatosensory, SS), SDX (1 mg/kg, i.p.), SBDZ
(5 mg/kg, i.p.), or IMI (15 mg/kg, i.p.) before being submitted to restraint. Immediately after stress, the animals were perfused and their
brains processed with immunohistochemistry for c-Fos (Ab-5 Oncogene Science). Dexamethasone reduced stress-induced c-Fos
expression in SS cortex, hippocampus, paraventricular nucleus of the hypothalamus (PVH), and locus coeruleus (LC), whereas diazepam
reduced c-Fos staining in the SS cortex, hippocampus, bed nucleus of stria terminalis, septal area, and hypothalamus (preoptic area and
supramammillary nucleus). Chronic administration of imipramine decreased staining in the hippocampus, PVH, and LC, while increasing it
in the nucleus raphe pallidus. We conclude that dexamethasone, diazepam and imipramine differentially modulate stress-induced Fos
expression. The present study provides an important comparative background that may help in the further understanding of the effects
of these compounds and on the brain activation as well as on the behavioral, neuroendocrine, and autonomic responses to stress.
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INTRODUCTION
The expression of immediate-early genes (IEGs) corre-
sponds to the activation of specific circuitry of the brain
related to perception and integration of primary stimuli as
well as to neuroendocrine, autonomic, and behavioral
responses. Immobilization stress for 30 min can induce
intense expression of c-Fos (and other IEGs) in several
brain areas such as alocortex and neocortex, lateral septal
area, paraventricular and dorsomedial nuclei of the
hypothalamus, retrochiasmatic area, medial and cortical
nuclei of the amygdala, periaqueductal gray matter, and
locus coeruleus (LC) (Cullinan et al, 1995). This widespread
and intense activation of CNS has been related to the
richness and complexity of the stress response. Stress
represents a complex orchestrated response to a stimulus
that may be coded at motor, sensory, autonomic, and
cognitive levels, and the activation of hypothalamic-
pituitary-adrenal (HPA) axis and of structures of autonomic
output represents but one of the primary manifestation of
these responses (Cullinan et al, 1995). The activation of
different brain structures can be part of facilitatory or
inhibitory circuitry on the HPA axis (Lachuer et al, 1994; Li
and Sawchenko, 1998; Herman et al, 2003).
Drugs, therapies, and behavioral procedures can alter the
neuronal activation induced by stress. Stress-induced c-Fos
expression can be modulated by different drug classes such
as antidepressants, anxiolytics, and glucocorticoids. Dex-
amethasone (a synthetic glucocorticoid) can reduce the
immobilization-induced expression of c-Fos RNAm in the
paraventricular nucleus of the hypothalamus (PVH) (Imaki
et al, 1995a). Benzodiazepines exert many effects, which
oppose those of corticotropin-releasing factor (CRF),
including anxiolysis and suppression of activation of the
pituitary–adrenal axis induced by stress (Imaki et al,
1995b). Diazepam, a benzodiazepine, inhibits the immobi-
lization-induced c-Fos expression in the brain cortex a
nd hippocampus of rats (Bozas et al, 1997). Anti-
depressant therapies, such as the chronic administration
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of electroconvulsive seizures, reduce the c-Fos expression
induced by stress in the rat frontal cortex (Morinobu et al,
1995). A similar effect occurs after chronic administration
of antidepressants, as imipramine, sertraline, tranilcipro-
mine, and desipramine (Morinobu et al, 1995).
There is considerable evidence on the clinical and
behavioral effects of psychoactive agents; however, there
are still many open questions with regard to the effects of
these drugs on stress induced of brain activation. Further-
more, when available, these studies most often assess the
effects of different agents only in a restricted number of
brain structures. Here, we evaluated three different proto-
typic compounds, dexamethasone (a synthetic glucocorti-
coid), diazepam (a benzodiazepine), and imipramine (an
antidepressant) in the immobilization-induced c-Fos ex-
pression over 40 different brain structures.
MATERIALS AND METHODS
Subjects
Adult, male, Wistar, albino rats, weighing 180–230 g, from
the local breeding facilities (CEDEME-UNIFESP) were used
in the present study. Animals were kept under conditions of
controlled temperature (23721C) and illumination (12/12 h
cycle, lights on at 0700 and had free access to water and
standard rat chow diet (Nuvilabs). All experimental
protocols were approved by the Animal Care and Use
Committee of UNIFESP being in accordance with NIH
guidelines on animal care. Experiments were carried out
between 0900 and 1200.
Experimental Design
Animals were then distributed into one of four groups
(Figure 1) as follows:
Somatosensory (SS) group (n¼ 5): animals were submitted
to 20 days of daily injection of saline and on the 21st day to
the injection of saline 60 min before the restraint stress.
SDX group (n¼ 5): animals were submitted to 20 days of
daily injection of saline and on the 21st day to the injection
of dexamethasone (1 mg/kg, i.p.) (Unlap and Jope, 1994)
60 min before the restraint stress.
SBDZ group (n¼ 5): animals were submitted to 20 days of
daily injection of saline and on the 21st day to the injection
of diazepam (5 mg/kg, i.p.) (Beck and Fibiger, 1995) 40 min
before the restraint stress.
IMI group (n¼ 5): animals were submitted to 20 days
of daily injection of imipramine (15 mg/kg, i.p.) (Morinobu
et al, 1995) and on the 21st day to the injection of
imipramine (15 mg/kg, i.p.) 60 min before the restraint
stress.
The time of treatment for the IMI group (20 days) was
based on the previous results demonstrating the need of a
chronic treatment with IMI for obtaining an antidepressant
effect (Morinobu et al, 1995). Based on the time for peak
plasma concentration of each drug, the time of drug
injection before the restraint was 40 min for the SBDZ
group and 60 min for the other groups.
For the restraint, rats were placed in a plastic cylinder for
60 min. Immediately after the period of restraint, stress
animals were anesthetized (Thiopental, 50 mg/kg) and
perfused transcardially with saline followed by 4% para-
formaldehyde in KPBS (pH 6.8) at 41C.
Immunohistochemistry
Brains were removed immediately after perfusion, stored
overnight in sucrose 30%, and the sections (32 mm) were cut
coronally on a cryostat. The sections were processed for the
immunohistochemical detection of c-Fos protein using a
conventional avidin–biotin–immunoperoxidase technique
to localize an antiserum raised against a synthetic N-
terminal fragment of human Fos protein (Ab-5, Oncogene
Sciences). Briefly, free-floating sections were pretreated
with hydrogen peroxidase for 10 min. Sections were treated
with normal goat serum (1:100) and 0.3% Triton X-100 for
2 h and incubated with the primary antiserum at a dilution
1:10 000 in KPBS at room temperature for 20 h. Subse-
quently, the sections were incubated with a secondary
antibody (goat anti-rabbit IgG 1:200FVector) for 90 min at
room temperature and treated with avidin–biotin complex
(Vector 1:100) for 90 min. Sections were submitted to
nickel-intensified diaminobenzidine reaction. Between
steps, the sections were rinsed in KPBS (pH 6.8) 0.05 M.
The tissue was agitated on a rotator between each
incubation and rinse step. Sections were mounted on
gelatin-coated slides, dried, dehydrated, and coverslipped.
To avoid eventual bias, at least one animal from each group
was included in every staining batch.
Cell Counting and Statistical Analysis
The nomenclature and nuclear boundaries defined in
Swanson’s stereotaxic rat brain atlas were used in this
study (Swanson, 1992). c-Fos-immunoreactive (Fos-ir)
nuclear profiles in different areas of the brain were counted
using a Nikon microscope coupled to a video camera and a
monitor. The boundaries of the brain areas were identified
using adjacent Nissl-stained sections. A template or outline
was developed for each brain nucleus or subnucleus based
Immobilization
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60 min
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Figure 1 Experimental design.
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on the shape and the size of the region (Kollack-Walker
et al, 1997). The location and relative size of each template
are illustrated in Figure 2. The number of c-Fos-positive cell
nuclei within each area was counted bilaterally (where
possible) in four to six consecutive sections per animal and
the average of them was expressed as number of cells Fos-ir/
10 000 mm2. For some of the evaluated nuclei, we decided to
provide a single cell count (rather than evaluating each
individual subnucleus) due to difficulties in consistently
defining its internal boundaries (eg bed nuclei stria
terminalis, ventral groups (BST‘v’) and bed nuclei stria
terminalis, dorsal groups (BNST‘d’)) and ventrolateral
medulla (VLM)). Stereological methods were not employed
in this study due to potential bias associated with counts
generated in this manner, such as uncertainties as to the
extent to which antiserum penetrates through the thickness
of the tissue sections and difficulties in defining the
boundaries of the several cell groups of interest. Moreover,
our interest was to make only relative comparisons of the
strength of Fos induction as a function of the treatment
status (Li and Sawchenko, 1998; Medeiros et al, 2003).
Statistical analysis of c-Fos expression was performed by
one-way ANOVA followed by Dunnett’s post hoc test. The
level of significance was set at Pp0.05. All values are
expressed as mean7SEM.
RESULTS
Staining of each individual Fos-ir cell varied from very
intense (black) to very light (light brown). To avoid double
counting or overcounting, only cells stained in dark brown
or black were considered for counting purposes. Staining of
the evaluated structures usually was seen over a wide range
of intensity for the different cells on a given brain structure.
In this sense, a decrease in the number of countable cells in
a given brain structure was generally accompanied by an
overall decrease in the intensity of staining in that structure
(ie there seemed to be a reduction of light- and moderate-
stained cells as well). In general, dark-stained cells did not
tend to cluster but rather seemed to be randomly
distributed on a given brain structure. Finally, animals
with a strong reduction of staining in one given nucleus did
not necessarily have reductions of similar degree in other
nuclei, that is, we found some variation from animal to
animal even for the same experimental group.
The c-Fos expression seen in the control group (animals
submitted to saline and restraint) was similar to that
previously reported for stress-induced c-Fos expression
(Senba et al, 1993; Chen and Herbert, 1995). It was widely
distributed in the brain, with moderate to intense staining
in areas involved with the stress response, such as limbic
structures and cell groups involved in neuroendocrine and
autonomic control (Table 1). Reliable induction of Fos-ir
was seen in the cortex, mainly in anterior cingulate area,
primary motor area, and visceral cortex (not counted).
Labeling in the other cortical areas, such as the hippocam-
pus for example, was quite sparse, even though we
consistently counted a few Fos-ir cells in the hippocampus
area in each section. In the bed nucleus, labeling was very
prominent and concentrated in the ventral nuclei (here
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Figure 2 Diagram illustrating the templates and relative sizes of the different brain areas subjected to counting of Fos-immunoreactive cells. The levels
were based on Swanson’s Stereotaxic Atlas of the Rat Brain. For abbreviations see Table 1 legend.
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grouped as BST‘v’). However, we also detected a robust c-
Fos expression in the dorsal groups of bed nuclei (BST‘d’).
Fos expression in the amygdaloid complex was generally
moderate, and while all recognized subdivisions contained
at least a few positive cells, the main part of these were
distinctly concentrated in the central nucleus of amygdala
(CEA). Fos induction in the septal complex comprised
principally a distinctive wedge-shaped group of cells in the
ventral part of the lateral septal nucleus (LSv) (Figure 4).
Labeling in the intermediate and dorsal parts of the lateral
septal nucleus was moderate and essentially absent in the
medial septal nucleus. The most marked Fos induction in
the thalamus was seen throughout many of the midline
(paraventricular nucleus of the thalamus (PVT)) and
intralaminar nuclei (central medial nucleus of the thalamus,
CM), while Fos induction in other thalamic areas was not
considerable. Restraint-induced Fos-ir in the hypothalamus
was concentrated mainly in the PVH, suprachiasmatic
(SCH) and supramammillary (SUMI), and preoptic and
periventricular (PVp (posterior periventricular nucleus of
the hypothalamus) and PVa (anterior periventricular
nucleus of the hypothalamus)) nuclei. Fos-ir neurons in
the PVH concentrated predominantly in the dorsal zone of
medial parvocellular part, with moderate expression in
almost all other parts of the parvocellular division, while
scarce in the magnocellular zone (Figure 3). Like most acute
systemic challenges, restraint also provoked Fos expression
in several structures of brain stem, recognized as compris-
ing a core of interconnected cell groups involved in central
autonomic and neuroendocrine control, as LC, nucleus of
tract solitary (NTS), parabrachial nucleus (PB), and VLM.
In the PB, labeling was generally sparse and concentrated
Table 1 Effect of Dexamethasone, Diazepam, and Imipramine
on the Immobilization-Induced c-Fos Expression in the Rat Brain
SS SDX SBDZ IMI
Cortex
ACA 0.70070.311 0.33370.193 0.23470.060 0.31470.071
MOp 0.83370.380 0.54270.217 034370.102 0.56870.047
SS* 0.32770.079 0.13370.033 0.08270.010 0.23770.059
Hippocampus
CA1* 0.21270.055 0.08070.012 0.07770.028 0.11070.028
CA2* 0.20270.042 0.08070.009 0.08770.016 0.09870.011
CA3* 0.20570.038 0.08770.023 0.09070.020 0.10570.02
GD 0.19570.048 0.10870.024 0.14870.035 0.13070.008
BST–amygdala
BST‘d’ 1.35570.239 0.73670.152 0.70970.225 0.85470.173
BST‘v’* 3.67770.739 2.31370.306 1.17370.439 2.02770.543
CeA* 1.79370.497 0.67570.189 2.24970.203 1.76270.343
MeA 0.70770.151 0.52370.750 0.48270.096 0.76270.143
CoA 0.21670.035 0.13970.046 0.13870.037 0.17470.031
BLA 0.83670.179 0,43170.077 0.41170.069 0.53370.071
Septal area
LSd 0.70370.211 0.44770.132 0.17570.058 0.53770.126
LSi* 4.63970.071 2.83570.088 1.58370.049 3.67570.045
LSv* 9.35671.20 7.86271.717 1.85070.584 7.11971.114
Thalamus–habenula
LH 3.09070.779 1.49070.778 1.65070.567 2.33070.662
CM 4.17571.017 1.94770.547 2.57271.017 2.44170.634
PVT 3.56570.676 2.00570.728 3.51070.938 2.53570.597
Hypothalamus
MPO* 2.47870.385 1.52470.402 1.09870.125 2.27270.192
SCH 13.82774.39 6.35574.544 9.70776.495 14.17673.76
PVa 2.44570.73 1.85070.705 2.59570.395 1.82070.276
HLA 1.02770.301 0.80570.223 0.43370.104 1.20570.277
ARQ 1.22570.478 0.64670.108 0.96070.254 0.56370.134
DMH 1.95670.408 1.06670.425 0.99870.224 1.39270.329
PH 1.11370.252 0.44970.087 0.66070.137 0.87570.160
PVp 3.22270.754 1.46770.256 1.63370.398 1.56770.502
SUMI* 4.25370.300 3.55570.435 2.43870.228 4.20870.143
PVHmpd* 35.51775.13 12.63372.71 28.11774.090 17.23372.59
Brain stem
MPT 1.14370.242 1.14270.376 1.34570.278 1.36070.356
PBl* 0.88770.111 0.50470.098 0.65470.086 1.51370.365
LC* 4.56970.500 1.76970.360 3.37570.337 2.44470.820
NTSl 12.6476.897 6.00671.733 9.14871.898 8.24073.886
NTSm* 15.01474.79 6.14571.579 31.21578.24 25.07876.47
VLM 0.61370.113 0.40070.045 0.52570.035 0.56570.089
Table 1 Continued
SS SDX SBDZ IMI
Raphe
DR* 1.74070.569 1.03570.305 1.08070.081 1.45070.228
RM 0.28770.032 0.30070.097 0.15570.058 0.14270.040
RO 0.12570.040 0.20870.029 0.22570.085 0.08370.032
RPA* 2.76770.918 2.76770.950 0.76770.292 5.83370.624
Abbreviations: ACA, anterior cingulate area; ARH, arcuate nucleus of the
hypothalamus; BLA, basolateral nucleus amygdala; BST‘d’, bed nuclei stria
terminalis, dorsal groups; BST‘v’, bed nuclei stria terminalis, ventral groups; CA1,
field CA1; CA2, field CA2; CA3, field CA3; CEA, central nucleus of the
amygdala; CM, central medial nucleus of the thalamus; COA, cortical nucleus of
the amygdala; DG, dentate gyrus; DMH, dorsomedial nucleus of the
hypothalamus; DR, dorsal raphe nucleus; LH, lateral habenula; LHA, lateral
hypothalamic area; LC, locus coeruleus; LSd, lateral septal nucleus, dorsal part;
LSi, lateral septal nucleus, intermediate part; LSv, lateral septal nucleus, ventral
part; MEA, medial nucleus amygdala; MOp, primary motor area; MPO, medial
preoptic area; MTP, medial pretectal nucleus; NTSl, nucleus of tract solitary,
lateral part; NTSm, nucleus of tract solitary, medial part; PBl, parabrachial
nucleus, lateral part; PH, posterior hypothalamus; PVa, anterior periventricular
nucleus of the hypothalamus; PVHmpd, paraventricular nucleus of the
hypothalamus, medial parvicellular part, dorsal zone; PVp, posterior
periventricular nucleus of the hypothalamus; PVT, paraventricular nucleus of the
thalamus; RM, raphe magno; RPA, nucleus raphe pallidus; RO, raphe obscurus;
SCH, suprachiasmatic nucleus; SS, somatosensory area; SUMI, supramammillary
nucleus; VLM, ventrolateral medulla.
*ANOVA, po0.05; numbers in bold indicate statistical difference from SS group
in the Dunnett’s post hoc test.
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mainly in dorsal lateral subnuclei, while in the NTS,
responsive neurons were concentrated mainly in the caudal
two-thirds of its medial division. In the LC (Figures 4 and
5), labeling was robust and distributed in all of its extension.
Restraint-sensitive neurons were distributed throughout the
ventrolateral medullary reticular formation from the caudal
pole of the facial motor nucleus to the spinal-medullary
transition area (Li and Sawchenko, 1998). Similar patterns
of c-Fos expression were previously described for foot-
shock-induced c-Fos expression (Li and Sawchenko, 1998).
Rats pretreated with dexamethasone and subsequently
immobilized had significantly fewer Fos-ir cells in the SS
a
c d
b
pml pml
pml
pml
PVHmpd
PVHmpd PVHmpd
PVHmpd
V3
V3
V3
V3
Figure 3 Photomicrograph illustrating the effect of dexamethasone, diazepam, and imipramine on stress-induced Fos-ir on the PVH. Animals were
submitted to daily injection of saline (a–c) or imipramine (d) for 20 days. On the 21st day, animals received (a) saline, (b) dexamethasone (1 mg/kg), (c)
diazepam (5 mg/kg), or (d) imipramine (15 mg/kg) before the restraint. After 1 h of restraint, the animals were evaluated for Fos-ir. Abbreviations: V3, 3th
ventricle; PVHmpd, paraventricular nucleus hypothalamus, medial parvicellular part, dorsal zone; pml, posterior magnocellular, lateral zone; scale bar 100 mm.
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cortex (60% reduction, SS¼ 0.32770.079 vs SDX¼
0.13370.033), in the hippocampus, with 58–62% reduction
in the fields CA1, CA2, and CA3, PVH (64% reduction),
and LC (61% of reduction), as compared to animals
pretreated with saline (Table 1 and Figures 3 and 5).
Despite the lack of statistically significant difference,
dexamethasone treatment also reduced by more than 50%
the number of Fos-ir cells in the CEA, lateral habenula (LH),
CM, SCH, medial preoptic area (MPO), PVp, and medial
part of the NTS (Table 1).
Figure 4 Photomicrograph illustrating the effect of dexamethasone, diazepam, and imipramine on stress-induced Fos-ir on the septal area. Animals were
submitted to daily injections of saline (a–c) or imipramine (d) for 20 days. On the 21st day, animals received (a) saline, (b) dexamethasone (1 mg/kg), (c)
diazepam (5 mg/kg), or (d) imipramine (15 mg/kg) before the restraint. After 1 h of restraint, the animals were evaluated for Fos-ir. Abbreviations: LV, lateral
ventricle; MS, medial septum; LSv, lateral septal nucleus, ventral part; scale bar 140 mm.
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Treatment with diazepam, as compared to saline controls,
significantly decreased stress-induced c-Fos expression,
yielding a 75% reduction in the SS cortex, between 57 and
64% reduction in different portions of the hippocampus
(eg CA1, CA2, and CA3), 68% reduction in the bed
nucleus of the stria terminalis, 66 and 80% reduction
in the intermediate parts of the lateral septal nucleus and
LSv, respectively (Figure 4), 56% in the MPO, and 43% in
the SUMI. In other areas, despite the lack of statistically
significant differences, diazepam caused a notable increase
in Fos expression in the NTS (107%) as well as a marked
reduction (72%) in the pallidus raphe nucleus.
Chronic administration of imipramine, as compared to
saline controls, produced a marked reduction on the
number of Fos-ir in the hippocampus (CA2 and CA3, with
48–52% fewer stained cells), in the PVH (51% less) and LC
(46% less), and increased in the raphe pallidus nuclei (111%
raise) (Table 1).
DISCUSSION
These results clearly show that dexamethasone, diazepam,
and imipramine differentially modulate stress-induced c-
Fos expression. The comparative analysis of the effects of
these drugs on the modulation of brain activation can
expand the comprehension of the mechanisms involved on
the effects of these drugs on stress responses.
Dexamethasone
Our results have shown that dexamethasone reduced the
c-Fos expression in areas related to sensory coding, such
as the SS cortex, as well as in limbic structures (eg
hippocampus), hypothalamic areas (PVH), and in areas
related to autonomic and neuroendocrine control (eg LC).
Previous findings by Imaki and colleagues have shown
that the chronic administration of dexamethasone inhibits
the induction of c-fos mRNA and CRF mRNA in the PVH
and plasma corticosterone and ACTH after stress (Imaki
et al, 1995a–c).
Possible mechanisms involved. The effect of dexametha-
sone on stress-induced c-Fos expression can be explained
by a downregulation of CRF through the inhibition of the
effects of protein kinase A pathways on CRF gene
expression at the transcription level (Imaki et al, 1995c).
CRF induces a pattern of c-Fos expression similar to that
induced by stress, and has been suggested to act in the CNS
influencing many responses to stress, raising the possibility
that a central CRF system may integrate multimodal
components of the organismic response to stress (Smagin
et al, 2001). Based on the close link between stress-induced
c-Fos expression and mRNA of CRF, the effect of
dexamethasone on the stress-induced c-Fos expression
would be mainly in areas with high densities of CRF
receptors. Our results are, at least in part, in agreement with
this hypothesis, since all brain areas where we detected an
a b
c
LC
LC
LCV4
V4
V4
d
LC
V4
Figure 5 Photomicrograph illustrating the effect of dexamethasone, diazepam, and imipramine on stress-induced Fos-ir on the LC. Animals were
submitted to daily injections of saline (a–c) or imipramine (d) for 20 days. On the 21st day, animals received (a) saline, (b) dexamethasone (1 mg/kg), (c)
diazepam (5 mg/kg), or (d) imipramine (15 mg/kg) before the restraint. After 1 h of restraint, the animals were evaluated for Fos-ir. Abbreviation: V4, 4th
ventricle; scale bar 150 mm.
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effect of dexamethasone have a moderate to high density of
mRNA or CRF receptors. However, a significant number of
areas with a high density of CRF receptors, such as lateral
septum, bed nucleus of terminalis stria, and dorsomedial
nucleus of the hypothalamus (Smagin et al, 2001), did not
present an altered Fos expression.
More recently, Ginsberg and colleagues have shown
dissociation between c-fos and CRF gene expression. In
this study, acute glucocorticoid treatment suppressed the
secretion of ACTH and CRF gene expression, but did not
affect c-Fos expression in the PVH (Ginsberg et al, 2003).
Irrespective of the mechanism involved in triggering
c-Fos expression in this area, which was not the subject of
the current investigation, there was a clear effect of
dexamethasone in the stress-induced c-Fos expression in
the PVH.
In addition, the effect of dexamethasone in different brain
structures could be discussed with regard to the distribution
of glucocorticoid receptors. The inhibition on c-Fos
expression caused by glucocorticoids has been related to
an interaction between proteins of the AP-1 complex and
the glucocorticoid–receptor complex. Binding of activated
glucocorticoid receptor to proteins of AP-1 complex (Fos or
c-Jun) can decrease the AP-1 activity and thus consequently
c-Fos expression (Unlap and Jope, 1994). However, the
areas in which we detected an effect of dexamethasone
could not be directly related to the areas with a high density
of glucocorticoid receptors (mainly type II that are more
sensitive to dexamethasone). Here again, we have not
detected a significant effect of dexamethasone on the stress-
induced c-Fos expression on the lateral septum that has a
high density of type II receptors (Magarin˜os et al, 1989). On
the other hand, we observed an effect of dexamethasone on
the LC that has high reactivity to glucocorticoid receptors
(Ha¨rfstrand et al, 1986).
Therefore, explanations based on CRF mechanisms or on
the density of glucocorticoid receptors are not by them-
selves sufficient to explain the effects of dexamethasone on
the restraint-induced c-Fos expression. The expression of c-
Fos as a consequence of stress is the result of a complex
interaction of pathways of cellular activation, and the effect
of dexamethasone depends on the neurochemical identity of
different cell type groups (eg, monoaminergic), the nature
of the challenge (kind of stress), and the dose of
corticosteroid among other factors (Li and Sawchenko,
1998; Ginsberg et al, 2003). Furthermore, not all corticos-
teroid-sensitive cells groups respond similarly to the
manipulation of the levels of glucocorticoids (Li and
Sawchenko, 1998).
Modulation of inputs to PVH. The stress-responsive CRF
neurons of the PVH summate excitatory and inhibitory
inputs into net secretory signals at the pituitary gland
(Herman et al, 2003). Based on this view, dexamethasone
reduced the activation not only of the PVH per se but also of
the structures that send direct excitatory inputs to the PVH
such as the LC (Ziegler et al, 1999). Besides, dexamethasone
has also been shown to reduce the c-Fos expression of the
hippocampus, another structure that modulates stress
responses (Kova´cs et al, 1986). The hippocampal inhibition
of the HPA is mediated by a set of neurons of the ventral
subiculum that project extensively to BST and hypothalamic
neurons relaying information to the PVH (Herman et al,
1995). Different from its effects on the LC, the effect of
dexamethasone on the hippocampus cannot be directly
related to a reduction of the activation of the PVH, given
that reductions of the hippocampal activation are related to
activation of the HPA axis. On the other hand, it has been
suggested that the inhibition of the HPA axis represents a
minor subset of hippocampal function and the steroids
receptors, which are richly expressed throughout the
hippocampus, can have other physiological actions, such
as encoding the significance of stressful events into memory
consolidation (Herman et al, 2003). These results suggest
that dexamethasone has not only a direct effect on the PVH
but also in structures that send excitatory inputs to PVH
and in structures related to the coding of emotional
stimulus.
Diazepam
Our results have shown that the treatment with diazepam
also reduced the restraint-induced c-Fos expression in areas
related to sensorial coding (eg SS cortex), in limbic
structures (eg hippocampus, the bed nucleus of the stria
terminalis, and the lateral septal nucleus), and in hypotha-
lamic areas (eg MPO and the SUMI).
Previous results of Beck and Fibiger (1995) have shown
that diazepam produced dose-related decreases in the
conditioned stress-induced c-fos expression. Accordingly,
the dose of 5 mg/kg of diazepam, but not 2.5 mg/kg, reduced
Fos induction in the cingulate, piriform, infralimbic and
retrosplenial cortices, CEA, LH, pretectal area, SUMI, and
median and pontine of raphe. However, at 5 mg/kg these
authors did not observe an effect in the LSv, PVT, CM, LC,
and dorsal raphe nucleus (DR) (Beck and Fibiger, 1995).
Our results agree, at least in part, with the above reported
study. Both studies have detected an effect of diazepam in
the SUMI, and not in the PVT, CM, LC, and DR. On the
other hand, the results were distinct for a number of other
studied areas. One possible explanation for these discrepant
results is that different kinds of stress (eg conditioned fear
vs restraint) can induce different patterns of c-Fos
expression and, consequently, show distinct sensibility to
diazepam. In this sense, administration of 10 mg/kg of
diazepam provoked a clear reduction on the c-Fos
expression induced by conditioned fear, whereas it did
not have effect on the expression induced by nicotine (Beck
and Fibiger, 1995; Salminen et al, 1996).
Possible mechanisms involved. One possible explanation
for the specificity of the effect of diazepam in the reduction
of c-Fos expression is the distribution of benzodiazepines
receptors in the CNS. Areas showing high densities include
the cerebral cortex, molecular layer of the cerebellum, and
parts of the limbic system, including amygdaloid complex,
hippocampal formation, piriform cortex, medial septal
nucleus, hypothalamus, and olfactory bulb (Young and
Kuhar, 1980; Richards and Mo¨hler, 1984). We detected an
important effect of diazepam in the lateral septal nucleus,
which has a moderate density of receptors, and did not
detect an effect on the amygdala, which has a high density of
receptors. Therefore, similar to the results seen with
dexamethasone, the areas where we detected an effect of
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diazepam cannot be directly related to the areas with a high
density of related receptors, suggesting that density of BDZ
receptors does not seem a critical factor for the encountered
effects on the c-Fos expression induced by stress.
Modulation of inputs to PVH. Similar to what was
discussed for dexamethasone, irrespective to the mechan-
isms, diazepam can change the stress responses by
modulation of inhibitory and excitatory inputs to the HPA
axis. Based on this view, although diazepam did not have
any effect on the c-Fos expression on the PVH, it has
reduced the activation of the MPO that sends direct
excitatory projections to PVH (Cullinan et al, 1996). On
the other hand, diazepam reduced the c-Fos expression in
areas that can inhibit as well as activate the HPA axis. In
this way, diazepam reduced c-Fos expression on the lateral
septal area, which innervates PVH-projecting regions
containing both GABAergic and glutamatergic neurons
(Herman et al, 2003). Diazepam also reduced c-Fos
expression in the hippocampus (Herman et al, 1995) and
bed nuclei (anterolateral nuclei) (Casada and Dafny, 1991),
areas that modulate the PVH. Diazepam also reduced c-Fos
expression on SUMIs, which does not have a defined role on
the excitability of the HPA. Although the mammillary nuclei
receives considerable input from limbic forebrain structures
and sends dense innervation to PVH (Price, 1995), the
function of these regions in the stress responses is ill
defined (Herman et al, 2003). Analysis of these data
suggests that the effect of diazepam directly on the PVH
or indirectly on the excitatory and inhibitory inputs to the
HPA was not sufficient to reduce the activation of PVH. In
spite of this, the brain areas where we detected an effect of
diazepam could be related to other aspects of the stress
response. The lateral septum, for example, has been
suggested to be a key mediator of anxiety states and the
principal site of action for antianxiety drugs (Gray and
McNaughton, 2000). In this sense, the diazepam effect could
be more related to the encoding of stressful events and not
only in the modulation of neuroendocrine responses to
stress.
Imipramine
Chronic treatment with 15 mg/kg daily of imipramine
reduced the c-Fos expression induced by restraint in limbic
structures (eg hippocampus), in areas related to autonomic
and neuroendocrine control (eg PVH and LC), and
increased it in brainstem structures (eg raphe pallidus
nuclei).
Previous results have shown that chronic, but not acute
treatment with imipramine (Morinobu et al, 1995), reduced
the swim stress-induced c-Fos expression in the PVH and in
limbic cortical regions, including the medial prefrontal,
ventrolateral orbital, and cingulate cortices, while no effect
was detected in the septal area, LH, amygdaloid complex,
and PVT (Duncan et al, 1996). Our results are in agreement
with those of Duncan and colleagues for some of the
seemingly more important structures studied, such as PVH,
amygdaloid complex, habenula, and the lateral septal area.
For the cingulate cortex and the bed nucleus, however, our
results are opposite to that reported above (Duncan et al,
1996).
Possible mechanisms involved. The mechanism(s) that
underlie the downregulation of c-fos induction by anti-
depressants could involve long-term adaptations of neuro-
nal function in response to chronic treatment (Morinobu
et al, 1995). It has been suggested that the downregulation
of b-adrenergic receptors and of some subtypes of serotonin
receptors (Heninger and Charney, 1987), adaptations in
intracellular mechanisms, such as the cAMP levels (Duman
et al, 1994), and activation of autoregulatory mechanisms
(Morinobu et al, 1995) can contribute to the antidepressant
effect on the c-Fos expression induced by stress. However,
none of these can separately explain this effect.
Modulation of inputs to PVH. The effect of antidepressants
on the c-Fos induction in the PVH has been previously
reported for different kinds of stressors (Duncan et al, 1996)
and is consistent with the clinical effects of antidepressants.
Antidepressant administration normalizes HPA hyperactiv-
ity that is frequently observed in depressed patients and this
effect is related to remission of depressive symptoms
(Linkowski et al, 1987). This reduction of the HPA axis is,
at least in part, consistent with our results showing a
reduction in the c-Fos expression in the PVH and in the LC
that send direct excitatory projections to PVH (Duman et al,
1994). The chronic administration of antidepressant re-
duced the burst rate and the tyrosine hydroxylase expres-
sion of LC (Nestler et al, 1990). The effect of stress on the LC
is mediated by CRF, which stimulates the adenylcyclase and
the cAMP levels in the LC (Duman et al, 1994). It suggests
that the reduction caused by imipramine, at least in the LC,
would balance the action of CRF and, consequently, reduce
c-Fos expression. On the other hand, imipramine reduced
the c-Fos expression in areas that send inhibitory projec-
tions to PHV, such as hippocampal CA2, and increased in
the raphe pallidus nuclei that have unidentified functions in
the HPA integration (Herman et al, 2003).
Overview
Comparing the effects of the studied drugs, differently from
dexamethasone and imipramine, diazepam did not affect
areas directly related to neuroendocrine output, such as the
PVH, or areas related to autonomic output, such as the LC.
In addition, the changes in other brain areas were also not
uniform, with diazepam not significantly affecting Fos
expression in the amygdala and imipramine increasing the
activation in the PR.
Hierarchical circuitry controlling HPA responsiveness.
Based on the view of Herman and colleagues, the central
mechanisms of stress integration would be the result of an
hierarchical circuitry controlling HPA responsiveness,
where the PVH summates excitatory and inhibitory inputs
into a net secretory signal at the pituitary gland (Herman
et al, 2003). Some structures that innervate PVH neurons
are primed to relay sensory information and promote
responses to emergent homeostatic challenges, while other
limbic structures are capable of activating the PVH in the
absence of frank physiological challenges responding in an
‘anticipatory’ manner. According to this view, drugs that act
in the stress response should promote early changes of the
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HPA responsiveness by direct action in PVH neurons or
indirectly by modulation of inputs, mainly inhibiting
excitatory or stimulating inhibitory projections. In this
sense, dexamethasone and imipramine were able to reduce
the c-Fos expression in the PVH and some of the regions
that send excitatory inputs to PVH. However, these drugs
also reduced c-Fos expression in structures that send
inhibitory inputs to PVH; furthermore, imipramine also
increased the c-Fos expression in some regions that do not
have a defined function in the HPA integration, even though
it sends excitatory inputs to PVH. Therefore, despite the
evident limitations of this circuit model, our hypothesis is
that dexamethasone and imipramine can reduce the stress
responses by modulation of both a lower circuitry
responsible by primary responses to stress (reflexive
pathway) and a higher circuitry related to the HPA
responsiveness and to encoding of stressful events (antici-
patory pathway). On the other hand, diazepam did neither
affect the PVH and nor reduced significantly c-Fos
expression of structures directly related to the HPA axis
excitability. Given the well-established clinical and experi-
mental effects of diazepam on stress responses, it seems
likely that its effects occur by modulation of neuronal areas
mainly related to encoding the significance of a stressful
event (anticipatory pathway).
Initiation and cessation of stress responses appears to be
choreographed by sets of hierarchical circuits converting
mono- or poly-sensory information into an integrated PVH
response. However, it is very hard to predict the signifi-
cance of each circuit on the stress response. A number of
inputs to the PVH are peptidergic or do not yet have a
clearly defined neurotransmitter, thus confusing the under-
standing of the precise action of each input on HPA
responsiveness. Furthermore, in a broader level, the kind of
stress represents an important experimental variable, which
should be considered, given that the magnitude of many
stress responses, including c-Fos expression, is stimulus
specific.
Comparing with the effect of the repeated stress, the effect
of these drugs on the stress-induced c-Fos expression was
restricted to some brain structures. Immobilization (2 h) for
13 consecutive days was able to reduce the immobilization-
induced c-Fos expression in most brain structures, includ-
ing amygdala, hypothalamus, thalamic nuclei, and cortical
areas (Medeiros et al, 2003). In this sense, the wide effect of
repeated stress can be related to the fact that the habituation
acted simultaneously in many circuits independently of
which neurotransmitters or intracellular mechanisms were
involved. In addition, even considering the potential
interaction between different neurotransmitting systems
and the action of a single drug in different intracellular
mechanisms, the effect of pharmacological agents are likely
to be more restricted.
The study of the consequences of different drugs on the c-
Fos expression induced by stress can help in the under-
standing of the clinical effects of these drugs. The neuronal
activation induced by different kinds of stress has distinct
sensitivity to the administration of anxiolitics (Bozas et al,
1997). Antidepressants also act differently in the reduction
of stress-induced c-Fos expression, and this antagonism has
been used for a functional classification of antidepressants
(Duncan et al, 1996). Recently, Sumner and colleagues have
concluded, in a meta-analysis study, that differences
between drugs classes support their classification by means
of c-fos profiling and that differences within classes may
reflect mechanistic variations (Sumner et al, 2004).
Despite the large number of studies evaluating the effects
of different clinically relevant drugs on several different
models of stress, there is relatively few comparative studies
using the same model with different drugs. Furthermore,
when available, these studies most often assess the effects of
different agents only in a restricted number of brain
structures. Our current effort in evaluating three different
prototypic compounds in a vast number of brain structures
thus provides an important comparative background that
may help in the further understanding of the areas involved
in stress and the effects of these compounds on stress.
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